Tactical Underweight: 15-20% trim at $193.54 with 80-85% residual, hard stop $187, three-path re-engagement framework
Escalate to tactical Underweight with 15-20% trim at $193.54 rather than passive Hold or aggressive Overweight. Historical alpha record at this configuration shows 15-20% Underweight trim produced +1.1% alpha (9/15) vs. -0.4% to -1.1% for Holds and -2.8% for 9/16 Overweight. Maintain 80-85% residual exposure to structural thesis while hard stop at $187 enforces risk discipline. Execute tranche completion within 3-5 sessions; re-engage via three-path framework only on confirmed reversal signals.
| Position | Action |
|---|---|
| Execute 15-20% trim immediately at ~$193.54 | Preserve 80-85% of position to maintain structural compounding exposure |
| Hard stop on remaining position | Below June lows and Bollinger lower band at $187 |
| Tranche completion timing | Within 3-5 sessions per empirical reflection |
| No adding at $193.54 | Reject aggressive sizing into broken momentum with expanding negative MACD |
| No trimming at $207-210 | Execute trim now per 9/04 and 9/15 reflections, not on rally |
RTX's $289 billion contracted backlog, doubling FCF, 520bps operating margin expansion, and multi-year defense supercycle make the current technical weakness a buying opportunity into fundamental strength.
| Indicator | Value | Signal |
|---|---|---|
| Close Price | $193.54 | neutral |
| 10 EMA | $198.19 | bearish |
| 50 SMA | $207.71 | bearish |
| 200 SMA | $192.84 | neutral |
| RSI | 29.75 | bearish |
| MACD | -4.42 | bearish |
| MACD Signal | -3.22 | bearish |
| MACD Histogram | -1.19 | bearish |
| Bollinger Middle (20 SMA) | $203.37 | bearish |
| Bollinger Lower Band | $190.06 | neutral |
| Bollinger Upper Band |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close > $200 on volume >5M with RSI >35
Then: Partial add
Operating margin expanded 520 basis points in 24 months, creating fortress-quality earnings
↩ rebuts: “Bear's 'priced for execution' claim ignores that execution is already reflected in historical results”
EV: +27% · concedes: Near-term technicals are indeed bearish (RSI oversold, 200 SMA test underway); Premium valuation relative to Lockheed (17x) and Northrop (18x); Commercial aerospace cyclicality poses some risk to Collins/Pratt segments; MACD at -4.42 indicates momentum laggard in short term
The market's price action is the ultimate arbiter, and it's signaling a strong downtrend: the 50 SMA is decisively broken, RSI is pinned below 30, momentum is accelerating lower, and premium valuation cannot hold when technical structure collapses and fundamental yellow flags (receivables build, thin liquidity) emerge.
EV: Base case consolidation in $185–$200 range
→ vs conservative: The tiered entry triggers at $200, $207, and $215 are exit signals in disguise—by the time price reaches those levels, the asymmetric upside has already compressed
→ vs conservative: 24.7x P/E premium to Lockheed (17x), Northrop (18x), GD (20x) is a feature, not a bug, due to commercial aerospace lever those pure-plays lack
→ vs conservative: The 'expensive' critique is a lazy anchor to pure-defense comps ignoring 50% of RTX's earnings power from commercial aerospace
→ vs conservative: Waiting for 'confirmation' before adding is demanding recovery to levels that already eliminate the asymmetric upside—that's risk aversion masquerading as risk management
→ vs conservative: RSI sub-30 with ATR contraction historically produces capitulation lows followed by sharp reversions in high-quality names 60-70% of the time
→ vs conservative: Signed government contracts (Tomahawk $22.9B, SM-3 framework Aug 14, space weapons architecture, survivable communications) are confirmation—the 'wait for confirmation' framework is intellectually incoherent
→ vs conservative: The pattern of waiting for confirmation produces missed entries, violent short-covering rallies at SMA, and chasing at higher prices
| $216.68 |
| neutral |
| ATR | $4.10 | neutral |
Support: 192.84 · 191.86 · 190.06 · 187 · 188 | Resistance: 198.19 · 200 · 203.37 · 207.71
RTX has undergone a sharp bearish reversal from its August peak, with price decisively breaking below both the 10 EMA and 50 SMA. The 200 SMA at $192.84 represents the last major technical support, with price hovering just $0.70 above this critical level. Momentum indicators are firmly bearish: MACD has crossed below its signal line with histogram widening (-1.19), and RSI has entered sustained oversold territory at 29.75. The path of least resistance remains down until the 200 SMA support is decisively resolved or the 50 SMA at $207.71 is reclaimed.
Market Cap
$260.85 B
P/E Ratio (TTM)
34.0x
Forward P/E
24.7x
PEG Ratio
2.28
P/B Ratio
3.93x
Dividend Yield
1.48%
Beta
0.287
Book Value / Share
$49.25
Revenue TTM
$93.50 B
Revenue 2025
$88.60 B
Gross Profit 2025
$17.79 B
Gross Margin
20.1%
Operating Income 2025
$9.30 B
Operating Margin
10.5%
EBITDA 2025
$14.95 B
EBITDA Margin
16.9%
Net Income 2025
$6.73 B
Profit Margin
8.28%
Diluted EPS 2025
$4.96
Forward EPS
$7.85
Tax Rate
19.1%
Diluted Shares Outstanding
1,356 M
Total Assets
$171.08 B
Total Debt
$39.51 B
Long-Term Debt
$34.29 B
Net Debt
$30.47 B
Net Debt / EBITDA
~2.0x
Stockholders' Equity
$65.25 B
Tangible Book Value
($19.94) B
Cash & Equivalents
$7.44 B
Receivables
$14.70 B
Inventory
$13.36 B
Total Current Assets
$60.33 B
Goodwill
$53.34 B
Other Intangibles
$31.85 B
Net PPE
$18.76 B
Accounts Payable
$15.90 B
Current Deferred Revenue
$21.62 B
Total Current Liabilities
$58.78 B
Current Ratio
1.011
Operating Cash Flow 2025
$10.57 B
Capital Expenditure 2025
($2.63) B
Free Cash Flow 2025
$7.45 B
FCF Margin
8.4%
Acquisitions/Divestitures 2025
$1.93 B
Debt Repaid 2025
($3.43) B
Dividends Paid 2025
($3.57) B
Buybacks 2025
($0.05) B
Net Cash Change 2025
$1.82 B
ROE
12.27%
ROA
4.21%
Free Cash Flow Yield
~3.8%
52-Week High
$226.88
52-Week Low
$155.64
50-Day Moving Average
$208.10
200-Day Moving Average
$193.94
Strengths
Concerns
RTX Corporation demonstrated strong operational improvement in 2025 with revenue of $88.60 billion (up 9.7% YoY), operating margin expanding to 10.5%, and free cash flow surging to $7.45 billion from $3.92 billion the prior year. The balance sheet shows successful deleveraging with net debt declining to $30.47 billion (Net Debt/EBITDA of ~2.0x), though receivables grew 33% outpacing revenue growth—a potential working capital concern. Valuation is premium at 34x TTM P/E, though the forward P/E of 24.7x is more reasonable, reflecting the market's positive view of the commercial aerospace recovery and defense backlog.
Macro: Hawkish Fed regime with 95% probability of zero rate cuts in 2026 (up 2.7pp wow); 10Y Treasury yields easing; oil near $100 on Iran-war supply concerns; US recession odds at 10% (+2pp wow). Pure defense plays are relatively insulated from rate hikes due to multi-year funded contracts, but commercial aerospace (Collins, Pratt & Whitney) faces oil-driven headwinds.